Literature DB >> 10348315

Normal ascorbic acid in cerebrospinal fluid of patients with infantile neuronal ceroid-lipofuscinosis.

J O Sass1, D Skladal, M Brunner-Krainz.   

Abstract

Neuronal ceroid-lipofuscinoses (NCL) are a group of neurodegenerative disorders. There is much evidence for a role of peroxidation processes in the pathogenesis of NCL, although this would certainly be indirect. Reduced total antioxidant activity of cerebrospinal fluid (CSF) has been reported in NCL. Since ascorbic acid represents a major antioxidant in CSF, we have now determined this parameter in CSF of two patients with the infantile form of NCL (Santavuori-Haltia disease). However, the ascorbic acid values obtained (103.6 and 181.3 microM) are comparable with control values from the literature as well as with those measured in groups of children with neurologic/psychiatric diseases other than NCL (mean +/- standard deviation: 137.1+/-41.3 microM), with suspected (but excluded) meningitis (124.1+/-34.0 microM) and acute lymphoblastic leukemia (131.7+/-17.0 microM). Our results indicate that CSF ascorbic acid concentrations are not affected by peroxidation processes in infantile NCL, but reveal a sharply decreased ascorbic acid concentration in one of the non-NCL patients, possibly associated with his convulsions and/or his anticonvulsant therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348315     DOI: 10.1023/a:1020613631353

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  20 in total

Review 1.  Vitamin C: antioxidant or pro-oxidant in vivo?

Authors:  B Halliwell
Journal:  Free Radic Res       Date:  1996-11

2.  Ascorbic acid concentrations in human plasma and cerebrospinal fluid [proceedings].

Authors:  B D Ridge; E Fairhurst; D Chadwick; E H Reynolds
Journal:  Proc Nutr Soc       Date:  1976-09       Impact factor: 6.297

3.  Decreased erythrocyte glutathione peroxidase activity in neuronal lipofuscinosis (NCL) - corrected with selenium supplementation.

Authors:  T Westermarck; M Sandholm
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-01

4.  Normal superoxide radical production in the neuronal ceroid-lipofuscinoses.

Authors:  B C Kieseier; K E Wisniewski; G Schuller-Levis; E Park; H H Goebel
Journal:  Neuropediatrics       Date:  1996-08       Impact factor: 1.947

5.  The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity.

Authors:  K Lönnrot; T Metsä-Ketelä; G Molnár; J P Ahonen; M Latvala; J Peltola; T Pietilä; H Alho
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

6.  Cerebrospinal fluid ascorbic acid levels in neurological disorders.

Authors:  R H Brau; S García-Castiñeiras; N Rifkinson
Journal:  Neurosurgery       Date:  1984-02       Impact factor: 4.654

7.  Cerebrospinal fluid ascorbic acid levels during the neonatal period.

Authors:  I Arad; M Regev; O Peleg; L Salpeter
Journal:  Int J Vitam Nutr Res       Date:  1991       Impact factor: 1.784

8.  Antioxidant treatment in Spielmeyer-Sjögren's disease.

Authors:  P Santavuori; T Westermarck; J Rapola; P Pohja; R Moren; M Lappi; U Vuonnala
Journal:  Acta Neurol Scand       Date:  1985-02       Impact factor: 3.209

9.  Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease.

Authors:  P Santavuori; H Heiskala; T Westermarck; K Sainio; R Moren
Journal:  Am J Med Genet Suppl       Date:  1988

10.  Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses.

Authors:  P Maertens; P Dyken; W Graf; C Pippenger; R Chronister; A Shah
Journal:  Am J Med Genet       Date:  1995-06-05
View more
  1 in total

Review 1.  Application of Anticonvulsants, Antiepileptic Drugs, and Vitamin C in the Treatment and Analysis of Batten Disease.

Authors:  Shreya Reddy; Hetal Brahmbhatt
Journal:  Cureus       Date:  2022-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.